Camillo Ricordi, M.D.
Dr.
Ricordi spent four years (1989-1993) as Director of Cellular Transplantation
at the University of Pittsburgh Transplantation Institute. Since 1993,
he has been at the University of Miami, where he holds the Stacy Joy
Goodman Chair. He serves as Professor of Surgery, Medicine, Biomedical
Engineering, Pathology, Microbiology and Immunology. Dr. Ricordi is
also Chief of the Division of Cellular Transplantation, Department of
Surgery, and Scientific Director and Chief Academic Officer of the Diabetes
Research Institute. Dr. Ricordi was president of the Cell Transplant
Society (1992-94), co-founder of the National Diabetes Research Coalition
(Chairman 1997) and president of the International Association for Pancreas
and Islet Transplantation (1999-2001; IPITA). Currently a member of
the council of the International Transplantation Society, he also served
on the council of the American Society of Transplant Surgeons (2000-2002).
Dr. Ricordi is also serving on the NIH/NCRR Islet Cell Resources (ICRs)
Executive Committee, as Chairperson of the Clinical Islet Transplant
Consortium (NIDDK-NIAID), on the NIH-NIDDK Strategic Planning Committee,
and on the NIH Expert Panel on Transplantation Research. Dr. Ricordi
is also known for inventing the machine (pictured) that made it possible
to isolate large numbers of islet cells from the human pancreas. He
performed the first series of clinical islet transplants that reversed
diabetes after implantation of donor purified islets into the liver
of recipients with diabetes.
Diabetes Research Institute
Return to Who is in the CIT Consortium
|